Literature DB >> 15057553

[Altered function of the hypothalamic-pituitary-adrenal axis in patients with acute, chronic and episodic pain].

M Strittmatter1, O Bianchi, D Ostertag, M Grauer, C Paulus, C Fischer, S Meyer.   

Abstract

INTRODUCTION: Complex disorders of the hypothalamic-pituitary-adrenal axis constitute phenomena whose etiopathogenetic significance is the subject of controversy. The frequent coincidence with depressive symptoms further complicates interpretation. PATIENTS AND METHODS: Daily variations in cortisol levels were measured in 20 patients with acute pain, 27 with chronic pain in the lumbar musculoskeletal system, and 44 with episodic forms of headache to determine the daily average and then correlated with differentiated algesimetric data.
RESULTS: Patients with chronic and episodic pain had significantly higher scores on the McGill Pain Questionnaire and more affective items as an expression of depressive symptoms than patients with acute pain. The three groups did not however exhibit significant differences for the depression scale and list of "psychovegetative" disorders. In comparison to an age-matched pain-free control population (n=17), the average daily levels of cortisol were significantly higher in all three groups besides singularly elevated daily levels, but no correlations between the cortisol values and overall algesimetric data could be established. Chronic pain patients with high depression scores had significantly higher cortisol levels irrespective of pain intensity. DISCUSSION: Pain experiences cause increased plasma cortisol levels with significant elevation of the daily average. Whereas in cases of acute pain, a direct but unspecific stress reaction not connected with the pain seems to be likely, the underlying cause in cases of chronic and episodic pain appears to be a complex and enduring activation of the hypothalamic-pituitary-adrenal axis, likewise independent from pain, probably associated with concomitant depressive symptoms and disruption of the circadian rhythm of release controlled by the hypothalamus.

Entities:  

Mesh:

Year:  2005        PMID: 15057553     DOI: 10.1007/s00482-004-0330-6

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  35 in total

1.  Autonomic nervous system and neuroendocrine changes in patients with idiopathic trigeminal neuralgia.

Authors:  M Strittmatter; M T Grauer; C Fischer; G Hamann; K H Hoffmann; F Blaes; K Schimrigk
Journal:  Cephalalgia       Date:  1996-11       Impact factor: 6.292

2.  The German counterpart to McGill Pain Questionnaire.

Authors:  Christoph Stein; Gabriela Mendl
Journal:  Pain       Date:  1988-02       Impact factor: 6.961

3.  Circadian rhythms of women with fibromyalgia.

Authors:  E B Klerman; D L Goldenberg; E N Brown; A M Maliszewski; G K Adler
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

Review 4.  [Hormonal perturbations in fibromyalgia].

Authors:  J L Schlienger; A E Perrin; F Grunenberger; B Goichot
Journal:  Ann Endocrinol (Paris)       Date:  2001-12       Impact factor: 2.478

5.  Melatonin levels in women with fibromyalgia and chronic fatigue syndrome.

Authors:  A Korszun; L Sackett-Lundeen; E Papadopoulos; C Brucksch; L Masterson; N C Engelberg; E Haus; M A Demitrack; L Crofford
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

Review 6.  Evaluation and management of endocrine dysfunction in fibromyalgia.

Authors:  Rinie Geenen; Johannes W G Jacobs; Johannes W J Bijlsma
Journal:  Rheum Dis Clin North Am       Date:  2002-05       Impact factor: 2.670

7.  Altered activity of the sympathetic nervous system and changes in the balance of hypophyseal, pituitary and adrenal hormones in patients with cluster headache.

Authors:  M Strittmatter; G F Hamann; M Grauer; C Fischer; F Blaes; K H Hoffmann; K Schimrigk
Journal:  Neuroreport       Date:  1996-05-17       Impact factor: 1.837

8.  Endogenous opioid tone in patients with rheumatoid arthritis.

Authors:  D Kassimos; E H Choy; A B Grossman; I C Chikanza; G S Panayi
Journal:  Br J Rheumatol       Date:  1996-05

Review 9.  Depression and cancer: mechanisms and disease progression.

Authors:  David Spiegel; Janine Giese-Davis
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

10.  Cortisol level predicts myocardial infarction in patients with ischaemic chest pain.

Authors:  R J Bain; V J Poeppinghaus; G M Jones; M J Peaston
Journal:  Int J Cardiol       Date:  1989-10       Impact factor: 4.164

View more
  5 in total

1.  [The cortisol awakening response in patients with acute and chronic low back pain. Relations with psychological risk factors of pain chronicity].

Authors:  S Sudhaus; B Fricke; S Schneider; A Stachon; H Klein; M von Düring; M Hasenbring
Journal:  Schmerz       Date:  2007-06       Impact factor: 1.107

2.  Exploring the relationship between disease-related pain and cortisol levels in women with osteoarthritis.

Authors:  L C Carlesso; J A Sturgeon; A J Zautra
Journal:  Osteoarthritis Cartilage       Date:  2016-06-29       Impact factor: 6.576

3.  Achieving Remission in Gulf War Illness: A Simulation-Based Approach to Treatment Design.

Authors:  Travis J A Craddock; Ryan R Del Rosario; Mark Rice; Joel P Zysman; Mary Ann Fletcher; Nancy G Klimas; Gordon Broderick
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

4.  Transitioning from acute to chronic pain: a simulation study of trajectories of low back pain.

Authors:  Jianzhong Su; Ying Du; Kelley Bevers; Pengcheng Xiao; John Licciardone; Marco Brotto; Robert J Gatchel
Journal:  J Transl Med       Date:  2019-09-06       Impact factor: 5.531

5.  Cytotoxic activity and subset populations of peripheral blood natural killer cells in patients with chronic pain.

Authors:  Jae Joon Yoon; Ji A Song; Sue Youn Park; Jeong Il Choi
Journal:  Korean J Pain       Date:  2018-01-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.